Emmanuel Osemota Foundation Community Outreach

PROBLEM AND SCALE OF PROBLEM

A rare disease is defined as one that affects fewer than 200,000 people across a broad range of possible disorders. It has been estimated that there are more than 6000 distinct rare diseases; all organ systems can be affected. More than 70% of rare diseases are genetic and most of them show a chronic course. The population prevalence of rare diseases was estimated to be 3.5%–5.9%, which equates to about 260–440 million individuals affected worldwide at any time. In Nigeria, 5 in 10,000 of the general population are affected (about 100,000 people), while in the US 1 in 10 people (or 30 million people) are affected. This large figure demonstrates the significance of rare diseases as a group, in particular since there is a great unmet medical need in the diagnostics, management, and treatment of these disorders. They are often chronic, progressive, and debilitating, and can lead to significant morbidity and mortality. 

FACTORS CONTRIBUTING TO THE PROBLEM RELATED TO OUR SOLUTION 

Although the group of rare diseases is heterogeneous, the diseases share common features and challenges, including lack of information, scarcity of expertise, delayed diagnosis, the chronic course of the disease, and no cure. The long diagnostic odyssey, lifelong disabilities, lack of compensatory support, and few but cost-effective treatments are some of the unmet needs that plague the lives of RD patients. 

The burden of rare diseases is approximately 10x higher than mass market diseases on a per patient per year (PPPY) basis. One of the primary challenges is the limited availability of specialized healthcare facilities and expertise. Rare diseases often require highly specialized knowledge and resources, which are concentrated in a few centralized healthcare institutions. This concentration creates geographic barriers, as families residing in remote or underserved areas struggle to access these specialized services. Moreover, even when families can overcome the geographical distance, financial constraints often make it unaffordable to seek out-of-area care.

The fragmented nature of the healthcare system exacerbates the problem. Rare disease families often find themselves navigating through a complex web of multiple healthcare providers, each specializing in a different aspect of their condition. This fragmented approach not only consumes valuable time and resources but also leads to communication gaps and inconsistencies in care, ultimately impacting the overall quality of life for the affected individuals.

Furthermore, the lack of comprehensive support systems adds to the burden faced by rare disease families. These families often require holistic care that addresses not only the medical aspects of the condition but also the emotional, social, and financial implications. However, there is a dearth of accessible resources and support networks that can cater to their unique needs, leaving them feeling isolated and overwhelmed.

Our solution combines the establishment of a community-based rare disease healthcare ecosystem with the implementation of Mobile Rare Disease Healthcare Units. By integrating these approaches, we aim to address the medical needs of rare disease families, promote collaboration, health education, and innovation, and create a more sustainable and patient-centric healthcare industry.

The community-based rare disease healthcare ecosystem serves as the foundation for our solution. It brings together a diverse range of stakeholders, including healthcare professionals, researchers, pharmaceuticals, technology providers, government agencies, and most importantly, the affected families. This collaborative network focuses on comprehensive care, research, education, and environmental sustainability.

To ensure accessibility and reach underserved communities, we're working towards the implementation of mobile rare disease healthcare units. These mobile healthcare units serve as a primary point of contact for rare disease families in remote and low-income areas. Equipped with medical equipment, diagnostic tools, genetic screening tools, and medications, the units provide on-site consultations, diagnostics, and treatments. By delivering healthcare services directly to the communities, these units reduce the need for families to travel long distances, minimizing transportation costs and carbon footprint as the healthcare units will be powered by electricity.

To further enhance the impact of our solution, we'll integrate telemedicine technologies into the unit. This enables real-time remote consultations with rare disease specialists located in centralized hospitals or medical centers. Through secure video conferencing and digital communication platforms, healthcare professionals in mobile units can connect with specialists for expert advice and guidance. This integration ensures that rare disease families in underserved areas have access to specialized expertise, regardless of their geographical location.

We will also prioritize comprehensive care, research, education, and technology integration:

·      Comprehensive Care: We establish community healthcare centers that offer specialized medical services, mental health support, and social services under one roof. These centers reduce the need for families to visit multiple facilities, lowering their carbon footprint and transportation costs. Advanced telemedicine technologies enable remote consultations, reducing physical travel requirements.

·      Research and Innovation: Collaboration among researchers, healthcare providers, and pharmaceutical companies is fostered to develop innovative treatments and therapies for rare diseases. We invest in research to identify environmentally friendly practices, such as sustainable medical waste management, energy-efficient infrastructure, and eco-friendly medication packaging.

·      Education and Awareness: Community outreach programs educate families and healthcare providers about sustainable practices, waste reduction, and recycling. By increasing environmental consciousness, we drive positive behavioral changes that contribute to a greener healthcare space.

·      Technology Integration: Digital platforms connect rare disease families, enabling resource and knowledge sharing. Data analytics identify patterns and trends, leading to better resource allocation and waste reduction strategies.

The implementation of our solution revolutionizes the rare disease healthcare subindustry. By showcasing the benefits of a community-based approach, we challenge the fragmented care model and inspire a shift towards integrated, patient-focused systems. This transformation leads to increased collaboration, knowledge sharing, and resource optimization within the rare disease space. As other organizations adopt similar models, the subindustry will witness improved healthcare outcomes, reduced environmental impact, and enhanced sustainability.

Our solution is designed to serve people living with rare diseases and their families. Rare diseases affect a small percentage of the population, but they have a significant impact on the individuals and families living with them. These families often face unique challenges in accessing specialized healthcare services, receiving timely and accurate diagnoses, and finding adequate support systems. Our target is to reach out to communities in low-income areas and communities in Nigeria. The financial burden of diagnosing and treating rare diseases is catastrophic in Africa and other low-income communities globally. 

Our prior engagements with these communities through our 501(c)(3) Emmanuel Osemota Foundation via community advocacy campaigns and data collection reveal a high financial burden of people living with rare diseases and the devastating impact on their families. This has allowed us to gain a fair understanding of the needs of this unique group of individuals in our target population. 

Our solution is designed to directly address the identified needs of rare disease patients and their families. By establishing a community-based rare disease healthcare ecosystem, we create a collaborative network that brings together healthcare professionals, researchers, pharmaceutical companies, technology providers, and government agencies. This network ensures that rare disease families have access to comprehensive care, specialized expertise, and the latest advancements in research and treatments.

Our team is uniquely positioned to deliver this solution to the target population because we have a deep understanding of and proximity to the communities we are serving. Over the years, and with philanthropic experience spanning three generations, we have actively worked with our target population empowering them through high-quality healthcare, education, and financial empowerment initiatives. This has given us great proximity and acceptance in our target communities. 

Our team understands the importance of co-creation and collaboration with the rare disease community. We believe that the solutions we develop should be acceptable and guided by their input, ideas, and agendas, and as such our solutions over the years have been  designed based on full consultation and active involvement of the target community. 

Here are some specific examples of how we are engaging with the communities we are serving:

• We conduct series of community needs assessments, as and when necessary, to understand the challenges faced by rare disease families in our target communities.
• We have held a number of community forums to get feedback on our solutions. 
• We have partnered with local and international organizations to raise awareness of rare diseases and our solution.
• We have created a community advisory boards to provide input on the design and implementation of our solution.

To achieve self-reliance and sustainability, we will continually seek meaningful guidance from the community for the design and implementation our solutions and ensure that their voices are represented, and their perspectives are incorporated into every aspect of our work.

We are applying for the Prize because we see it as a critical opportunity to address the specific financial barriers that we face in delivering our solution to the target population. Despite our dedication and passion for making a difference in the lives, limited financial resources have posed significant challenges in scaling up our operations and reaching more underserved communities. Scaling up our solution requires substantial financial investments in various areas, such as acquiring, developing, and equipping our mobile healthcare units, establishing our community-based healthcare initiatives and financing their operational expenses, financing our collaborative efforts, financial support to families and payment for other resources required for our different community projects.

With the financial support provided by the Prize, we can begin our operations and reach underserved communities that lack access to adequate rare disease healthcare. The Prize will also enable us to invest in telemedicine technologies, ensuring seamless remote consultations with specialists and enhancing the efficiency of our healthcare units and community-based healthcare initiatives.

The team lead of the Emmanuel Osemota Foundation, Emmanuel J. Osemota, is deeply connected to the communities in which the project is based. He was born and raised in Nigeria, and he currently works and lives between Nigeria and the US. He has a strong understanding of the challenges faced by rare disease families by the clients as he has been an advocate for the marginalized and less privileged for more than 15 years. He has worked diligently providing humanitarian aid for his home community and has empowered thousands of individuals through the Emmanuel Osemota Foundation.

In addition to his personal connection to the community, the Emmanuel Osemota Foundation has a long history of working with rare disease families in Nigeria. The foundation has established a network of community-based initiatives that facilitates easy access to specialized medical services, mental health support, and social services to rare disease families. The foundation also runs a number of educational and awareness programs that help to raise awareness of rare diseases in Nigeria.

The team lead's connection to the community and the foundation's work in the community make them well-positioned to implement the solution. They have a deep understanding of the needs of rare disease families in the target communities, and they have the experience and resources to make a real difference in the lives of these families. 

Our use of mobile healthcare units is a novel approach to reaching out to underserved communities in Nigeria. These units include medical equipment, diagnostic tools, and medications, allowing for on-site consultations, diagnostics, and treatments. We reduce the need for families to travel long distances by delivering healthcare services directly to communities, reducing transportation costs and carbon footprint.

The incorporation of telemedicine technologies into our units enables real-time remote consultations with specialists. Through video conferencing and digital communication platforms, healthcare professionals in mobile units can connect with specialists for expert advice and guidance. This ensures that rare disease families in underserved areas have access to specialized expertise, regardless of their geographical location.

Our solution prioritizes environmental sustainability by investing in eco-friendly practices. We focus on sustainable medical waste management, energy-efficient infrastructure, and eco-friendly medication packaging. By incorporating these practices into our operations, we reduce our ecological footprint and contribute to a greener healthcare space.

We will leverage digital platforms and data analytics to connect rare disease families, enabling resource and knowledge sharing.

In the first year of this project, our primary goals are centered around healthcare delivery, collaboration, health education, improving accessibility, expertise, and sustainability. Firstly, our aim is to enhance accessibility to specialized healthcare services for families with rare diseases residing in remote and low-income, and low-resource settings. To accomplish this, we will deploy mobile healthcare units, health education and promotion strategies, and interventions to these communities. 

Secondly, we are committed to ensuring that rare disease families in underserved areas have access to specialized expertise. By the end of the next year, we plan to integrate telemedicine technologies into our mobile units, allowing healthcare professionals in these communities to connect with specialists. This will bridge the gap between patients and specialized healthcare providers, offering a lifeline of support and knowledge. 

Additionally, we aim to serve as advocates for rare disease patients and their families, amplifying their voices and ensuring their needs are heard and met. We will actively engage with policymakers, healthcare organizations, and the public to raise awareness about the challenges faced by rare disease communities. By advocating for improved policies, increased research funding, and better access to care, we strive to create a more inclusive and supportive healthcare system for all. Together, with our dedication to health advocacy and our comprehensive solution, we aim to make a lasting impact on the lives of rare disease patients and their families.

Our impact goals in the next five years center around collaborative research and innovation, as well as improved healthcare outcomes for rare disease patients. Our foremost objective is to foster collaboration among researchers, healthcare providers, and pharmaceutical companies. Through the community-based ecosystem, we will create a platform for knowledge sharing, resource pooling, and collaboration. By fostering a culture of collaboration, we aim to accelerate the pace of research, leading to the development of innovative treatments and therapies for rare diseases. This collaborative effort will advance healthcare outcomes and bring hope to rare disease patients and their families.

Furthermore, we strive to achieve significant improvements in healthcare outcomes for rare disease patients. By integrating comprehensive care, research, education, and technology, we envision a future where patients receive holistic and personalized support. Our community healthcare centers will offer specialized medical services, mental health support, and social services under one roof. 

One of our primary objectives is to improve access to rare disease healthcare services, particularly in underserved communities. A singular important metric for tracking our success is the number of individuals living with rare diseases and their families we have reached and impacted per time by our solutions. In the first year, through our mobile healthcare units, we aim to have successfully reached out to and provided on-site consultations to over 1200 individuals and families in underserved communities with a projected annual growth rate of 20%. We will also target and provide diagnostics and treatments to at least 50% of them. By consistently expanding our reach, we ensure that more families have access to specialized care and guidance, bridging geographical gaps, and reducing disparities in healthcare access.

Our community outreach programs play a vital role in raising awareness and education. In the first year, we target to reach 5,000 individuals, including rare disease families and healthcare providers, through our programs. We aim to raise this number to over 10,000 individuals and over 500 communities in the next 5 years. By expanding the reach of our educational initiatives, we promote sustainable practices and drive positive behavioral changes. This number will be increased exponentially by the adoption of digital media platforms in providing health education and promotion about rare diseases, their signs, and symptoms, public misconceptions, and myths. 

To assess the impact of our community-based rare disease healthcare ecosystem, we will focus on comprehensive care and patient satisfaction. We will measure the percentage of patients who report satisfaction with the quality of care received through our community healthcare centers and mobile healthcare units. Our goal is to achieve a patient satisfaction rate of 90% or higher. Continuous feedback surveys and patient testimonials will serve as valuable tools for evaluating our progress and identifying areas for improvement.

Fostering collaboration and knowledge sharing is essential to driving advancements in rare disease treatment and therapy development. To measure our progress in this area, we monitor the number of collaborative research projects. To measure progress in this area, we will track the number of partnerships established with healthcare professionals, researchers, pharmaceutical companies, and technology providers. Our target is to form at least three (3) partnerships in the first year, with an annual growth rate of 10%. By the fifth year, we aim to have a total of at least  ten (10) collaborative partnerships in place. These partnerships will facilitate the exchange of expertise, innovative research, and best practices, driving advancements in rare disease healthcare.

Environmental sustainability is a core focus of our solution. In the first year, we aim for a 10% reduction in carbon emissions compared to traditional care models by monitoring our carbon footprint by assessing the amount of greenhouse gas emissions reduced through the use of renewable energy sources in our healthcare units. Over the subsequent years, we strive for an annual reduction rate of 15%, Concurrently, we aim to achieve a 20% reduction in waste production. 

The core focus of our solution is to improve access to healthcare services for rare disease families. Many families encounter significant barriers in accessing specialized care, such as long distances to healthcare facilities, limited resources, and knowledge and information gaps. By deploying mobile healthcare units, we aim to eliminate the geographical constraints and bring healthcare directly to these families. In addition to improved access, our solution promotes collaboration and innovation within the rare disease healthcare space. We bring together a diverse range of stakeholders, including healthcare professionals, researchers, pharmaceutical companies, technology providers, government agencies, and most importantly, the affected families themselves. 

This collaborative network fosters the sharing of knowledge, expertise, and resources, creating a platform for interdisciplinary collaboration. This collaborative approach empowers rare disease families by ensuring that their unique insights and experiences are incorporated into the healthcare system, leading to better care.

Sustainability is a key aspect of our solution. By integrating telemedicine technologies into our Mobile Rare Disease Healthcare Units, we reduce the need for physical travel and minimize transportation costs and carbon footprint. These units are powered by renewable energy, further aligning with our commitment to environmental sustainability. 

Additionally, we promote sustainable practices in research, education, and waste management. By investing in environmentally friendly practices such as sustainable medical waste management, energy-efficient infrastructure, and eco-friendly medication packaging, we strive to reduce the environmental impact of the rare disease healthcare industry. Through these sustainable practices, we aim to create a more environmentally conscious and responsible healthcare system.

Technology plays a central role in our solution to revolutionize access to healthcare for individuals living with rare disease and their families. It serves as a powerful enabler, driving positive change and transforming the way healthcare services are delivered. 

We will employ telemedicine technologies which are crucial in breaking down geographical barriers and ensuring access to specialized expertise. Through video conferencing and digital communication platforms, rare disease families in underserved areas can connect with specialists located in our centralized partner hospitals or medical centers. Similarly, our mobile healthcare units will be equipped with medical equipment and diagnostic tools, powered by renewable energy. These mobile units bring healthcare services directly to remote and low-income areas, ensuring that rare disease families have access to on-site consultations, diagnostics, and treatments. By leveraging technology, we bridge the healthcare gap and reach those who would otherwise face significant challenges in accessing medical care.

We will also utilize digital platforms in connecting rare disease families, healthcare professionals, researchers, and stakeholders. These platforms serve as a hub for resource and knowledge sharing, fostering collaboration and information exchange with resources produced in clear and understandable languages to our target communities. Digital platforms also facilitate communication and coordination among stakeholders, creating a holistic and integrated healthcare ecosystem. Via partnership and research participation, we will employ technology in the development of advanced genetic screening tools, data analytics, epidemiological data collection tools, and computational modeling to expedite the development of innovative treatments, therapies, and approaches. 

Full staff: 10

Part-time staff: 15

The Emmanuel Osemota Foundation founded in 2018, and we started actively working  on the problem of access to specialized healthcare for rare disease families in Nigeria in 2020. In the past 5 years, the foundation has provided specialized healthcare, mental health support, and social services to over 1,000 rare disease patients and their families, and it has provided medical, educational, and financial support to more than 5,000 individuals.

The Emmanuel Osemota Foundation is committed to incorporating diversity, equity, and inclusion into our work. We believe that a diverse and inclusive workforce is essential to our mission of providing quality healthcare to all people, regardless of their background.

Our leadership team is diverse in terms of gender, race, ethnicity, and professional experience. We have a team of experienced healthcare professionals, as well as people with experience in fundraising, law, and communications. We believe that this diversity of experience and perspective is essential to our ability to effectively address the challenges faced by rare disease families in Nigeria and other underserved communities. 

We are deeply committed to ensuring accessibility and affordability for all individuals, including marginalized communities and those with limited resources. We will actively work to remove barriers such as language, transportation, and cultural sensitivities to ensure equitable access to our healthcare services.

Our team's strategies for becoming more diverse, equitable, and inclusive include:

• Increasing the representation of experienced individuals from underrepresented groups in our leadership team
• Creating a more inclusive organization where all employees feel welcome, respected, and valued.
• Working with our partners to create more equitable healthcare systems in our catchment communities. 

We believe that these strategies are making a difference, and we are committed to continuing our work to create a more diverse, equitable, and inclusive organization.

Clients and Important Stakeholders:

• Rare disease patients and their families
• Healthcare professionals and researchers
• Pharmaceutical companies
• Technology providers
• Government agencies and policymaker

Value Proposition:

• Comprehensive rare disease healthcare services
• Accessible and convenient healthcare through mobile units
• Health care promotion, advocation, and education
• Integration of telemedicine for remote consultations
• Collaborative community-based healthcare ecosystem for people living with rare diseases. 
• Emphasis on sustainability and environmental consciousness

Channels:

• Community outreaches 
• Mobile rare disease healthcare units
• Community healthcare centers
• Telemedicine platforms 
• Digital communication
• Partnerships with local healthcare providers and organizations
• Online platforms and social media for knowledge sharing and increased awareness

Customer Relationships:

• Personalized care and attention to individual patient needs
• Establishing trust and long-term relationships with patients and families
• Acceptability of projects by communities
• Collaboration and engagement with healthcare professionals and researchers
• Continuous communication and feedback loops with stakeholders

Key Activities:

• Provision of on-site consultations, diagnostics, and treatments
• Research and development of innovative treatments and therapies
• Education and awareness programs for patients, families, and healthcare providers
• Integration of telemedicine technologies, mental health, and social support services.
• Building and maintaining collaborative networks

Key Resources:

• Medical equipment and diagnostic tools
• Genetic screening tools
• Medications and treatment options
• Skilled healthcare professionals and specialists
• Partnerships and collaborations with stakeholders

Key Partnerships:

• Healthcare providers and professionals
• Pharmaceutical companies 
• Technology providers for telemedicine integration
• Government agencies and policymakers
• Rare disease associations and advocacy groups

Revenue Streams:

• Donations
• Grants and funding from government agencies, foundations, and corporate organizations
• Partnerships and collaborations with healthcare providers and organizations
• Sponsorships and partnerships with pharmaceutical companies

Cost Structure:

• Operational costs for mobile units, equipment, and medications
• Salaries and training for healthcare professionals
• Research and development expenses
• Marketing and outreach activities
• Administrative and infrastructure costs

Impact Measurement:

• Number of rare disease patients served
• Reduction in travel distances and associated costs for patients
• Healthcare Outcomes and patient satisfaction
• Reduction in carbon footprint and environmental impact
• Collaborative research and innovation in rare disease treatment

GRANTS: BOTH PRIVATE AND GOVERNMENT

We have a history of receiving grants from government agencies and private foundations. These grants have helped us to fund our work and make a difference in the lives of people. We plan to continue to apply for grants in the future and continue to make best efforts to secure them.

CORPORATE PARTNERSHIPS

We have forged strategic partnerships with businesses, foundations, and other NGOs to support our financial sustainability. These partnerships have yielded increased financial contributions and additional resources to our foundation. We plan to continue to build these partnerships in the future, and we are confident that they will be a valuable source of funding for our work.

MAINTAIN AN ARMY OF INDIVIDUAL AND CORPORATE DONORS

We have a strong network of individual and corporate donors who are passionate about our mission. These donors have been generous in their support, and we are grateful for their continued commitment. We plan to continue to cultivate these relationships, as well as form new ones. 

CONSISTENT AWARENESS, PUBLICITY, AND ADVOCACY

We will continue to raise awareness about our organization and our work. We will do this through our website, social media, and other channels. We believe that increased awareness will lead to increased donations and support for our work.

STRATEGIC PARTNERSHIPS

We have forged strategic partnerships with businesses, foundations, and other NGOs mutual support. These partnerships will yield additional resources for organization. We therefore plan to continue to nurture them. 

FRUGAL ACCOUNTING AND COST EFFICIENCY

We will implement a number of cost-saving measures, such as reducing administrative costs and streamlining our operations. We will also ensure transparency and accountability in our operations. These measures will help us to improve our financial efficiency.

We believe that this diversified approach to resource sourcing and management will help us to achieve financial sustainability in the long term. We are confident that we will be able to continue to grow and sustain our foundation's work in the years to come.

1. Diversified Funding Sources: we have achieved financial sustainability over the years by relying on a mix of funding sources,  receiving grants from government agencies, corporate partnerships, individual donations. This diversified approach has helped us reduce reliance on a single source of funding.

2. Strategic Partnerships: We have forged strategic partnerships with businesses, foundations, and  other NGOs to support our financial sustainability. These partnerships have yielded increased financial contributions and additional resources to our foundation.

3. Cost-saving measures and strict accounting regimes: We have implemented a number of cost-saving measures, such as reducing administrative costs and streamlining our operations, and we have ensured transparency and accountability in our operations. These measures have helped us to improve our financial efficiency.

4. Leveraging our website and social media platforms to facilitate seamless individual and corporate donations.